Bio Plus Co., Ltd

Research Bio Plus Co., Ltd (099430.KQ) on Bullrun: market cap KRW 220.31B, dividend yield 2.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 220.31B; dividend yield is 2.0%.

Peer valuation comparison

Latest dividend yield is 1.96% versus a Healthcare sector median of 2.4% (18.3% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 220.31Bn/a2.0%70

Dividend history

Latest trailing dividend snapshot: annual dividend/share 70 KRW, yield 2.0%.

About Bio Plus Co., Ltd

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Bio Plus Co., Ltd's market cap?

Bio Plus Co., Ltd's market capitalization is KRW 220.31B.

Does Bio Plus Co., Ltd pay a dividend?

Bio Plus Co., Ltd has a dividend yield of 2.0%.

What does Bio Plus Co., Ltd do?

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms.